12:00 AM
 | 
Oct 14, 2013
 |  BC Week In Review  |  Company News  |  Deals

Ipsen, PeptiDream deal

Ipsen and PeptiDream added additional candidates and indications to their April 2013 deal to discover and develop therapeutic peptides to treat indications of...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >